CANTORE, ALESSIO
 Distribuzione geografica
Continente #
NA - Nord America 189
EU - Europa 182
AS - Asia 61
SA - Sud America 1
Totale 433
Nazione #
US - Stati Uniti d'America 188
SE - Svezia 103
IT - Italia 37
CN - Cina 31
SG - Singapore 25
RU - Federazione Russa 21
IE - Irlanda 6
DE - Germania 5
FI - Finlandia 4
JP - Giappone 4
ES - Italia 3
NL - Olanda 2
AR - Argentina 1
CA - Canada 1
CH - Svizzera 1
HK - Hong Kong 1
Totale 433
Città #
Ashburn 36
Shanghai 22
Lawrence 21
Princeton 21
New York 20
Boardman 17
Singapore 14
Los Angeles 8
Milan 8
Moscow 7
Dublin 6
Washington 5
Helsinki 4
Ancona 3
Dallas 3
Arezzo 2
Barcelona 2
Bologna 2
Clusone 2
Florence 2
Genoa 2
Guangzhou 2
Gunzenhausen 2
Nerviano 2
Rome 2
Beijing 1
Borås 1
Brugherio 1
Chiaravalle 1
Fontana 1
Formia 1
Frankfurt am Main 1
Genova 1
Hanover 1
La Plata 1
Macerata 1
Molina de Segura 1
Montreal 1
Piemonte 1
Redwood City 1
San Francisco 1
Seattle 1
Segrate 1
Tokyo 1
Viadana 1
Weitang 1
Zurich 1
Totale 237
Nome #
Laboratory-Scale Lentiviral Vector Production and Purification for Enhanced Ex Vivo and In Vivo Genetic Engineering 31
Dynamics and genomic landscape of CD8+ T cells undergoing hepatic priming 31
Site-specific integration and tailoring of cassette design for sustainable gene transfer 25
A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice 24
In vivo Gene Therapy to the Liver and Nervous System: Promises and Challenges 22
Phagocytosis-shielded lentiviral vectors improve liver gene therapy in nonhuman primates 21
ENDOGENOUS MICRORNA CAN BE BROADLY EXPLOITED TO REGULATE TRANSGENE EXPRESSION ACCORDING TO TISSUE, LINEAGE AND DIFFERENTIATION STATE 19
WFH State-of-the-art paper 2020: In vivo lentiviral vector gene therapy for haemophilia 19
Retrieval of vector integration sites from cell-free DNA 19
Liver-directed lentiviral gene therapy in a dog model of hemophilia B 18
In vivo delivery of a microRNA-regulated transgene induces antigen-specific regulatory T cells and promotes immunologic tolerance 17
Genome editing for scalable production of alloantigen-free lentiviral vectors for in vivo gene therapy 17
Hyperfunctional coagulation factor IX improves the efficacy of gene therapy in hemophilic mice 16
Therapeutic liver repopulation by transient acetaminophen selection of gene-modified hepatocytes 16
Insulin B chain 9-23 gene transfer to hepatocytes protects from type 1 diabetes by inducing Ag-specific FoxP3+ Tregs 15
Targeting Integration to Selected Genomic Loci and In Situ Tailoring of Cassette Design Allows Robust Transgene Expression without Perturbing Endogenous Transcription 15
Mouse Models To Assess the Risk of Vector Insertional Mutagenesis upon Systemic Delivery 15
Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigen-specific tolerance in mice with low genotoxic risk. 15
Liver gene therapy by lentiviral vectors reverses anti-factor IX pre-existing immunity in haemophilic mice 15
Liver-directed lentiviral gene therapy corrects hemophilia A mice and achieves normal-range factor VIII activity in non-human primates 14
Modulation of immune responses in lentiviral vector-mediated gene transfer 14
GP64-pseudotyped lentiviral vectors target liver endothelial cells and correct hemophilia A mice 13
Regenerative medicine: the red planet for clinicians 13
In vitro differentiation of human Mesenchymal Stem Cells from various sources 12
null 11
In vivo models to assess the risk of insertional mutagenesis in the liver upon vector systemic delivery 11
Isolation and in vitro differentiation of human Mesenchymal Stem Cells from new alternative sources: fetal membranes and placenta 11
LSpECifying transgene expression 7
In vivo generation of CAR T cells in the presence of human myeloid cells 4
Totale 480
Categoria #
all - tutte 5.836
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.836


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204 0 0 0 2 1 0 0 0 0 1 0 0
2020/202111 0 0 0 2 3 5 1 0 0 0 0 0
2021/202239 0 0 0 18 4 1 4 2 1 0 3 6
2022/2023164 48 38 16 7 2 26 7 8 4 3 5 0
2023/2024200 1 3 35 35 15 29 8 16 3 8 18 29
2024/202552 43 9 0 0 0 0 0 0 0 0 0 0
Totale 480